Medicine and Dentistry
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
6%
Age
8%
Analysis
10%
Artificial Respiration
6%
Asthma
12%
Azithromycin
6%
Biological Marker
17%
Cancer
6%
Carbon Monoxide
6%
Case Management
6%
Chronic Disease
6%
Chronic Obstructive Pulmonary Disease
50%
Cognition
6%
Cohort Analysis
10%
Computer Assisted Tomography
12%
Cost-Effectiveness Analysis
7%
COVID-19
24%
Development
6%
Diagnosis
8%
Disease Exacerbation
6%
Diseases
8%
Drug Therapy
7%
Dyspnea
9%
Follow up
11%
Hemoptysis
6%
Hospital
20%
Hydroxychloroquine
6%
Inpatient
33%
Intensive Care Unit
7%
Life
6%
Lung Cancer
9%
Measurement
7%
Mortality
10%
Nasal Cannula
24%
Neoplasm
6%
Non Small Cell Lung Cancer
6%
Open-Label Trial
6%
Oxygen
15%
Oxygen Therapy
6%
Patient
100%
Pleura Mesothelioma
12%
Prophylaxis
6%
Pseudomonas aeruginosa
6%
Radiation Therapy
8%
Respiratory Failure
14%
Silo-Filler's Disease
5%
Statistical Analysis
6%
Symptom
5%
Therapeutic Procedure
39%
Woman
7%
Nursing and Health Professions
Ambulance
6%
Comorbidity
6%
Computer Assisted Tomography
6%
Cross-Sectional Study
5%
Dyspnea
10%
Flow
9%
Hemoptysis
6%
Hospital
5%
Hospital Readmission
6%
Hospitalization
9%
Inpatient
11%
Mortality
7%
Nasal Cannula
18%
Obstructive Lung Disease
61%
Patient
43%
Pilot Study
6%
Procedures
8%
Quality Adjusted Life Year
5%
Quality of Life
6%
Tuberculosis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Azithromycin
6%
Chronic Obstructive Lung Disease
59%
Clinical Trial
5%
Cohort Study
10%
Comorbidity
6%
Corticosteroid
6%
Death
5%
Diseases
10%
Hydroxychloroquine
6%
Mortality
6%